| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |